JUBLPHARMA Breakout after 2018
Below are the some points to go through for better analysis:
1. Breakout after 2018
2. Risk Reward is almost 2.5.
3. Did not fall even Nifty fall
Disclaimer:
Content shared on or through social site channels are for information and education purposes only and should not be treated as investment or trading advice. Please do your own analysis or take independent professional financial advice before making any investments based on your own personal circumstances. Investment in securities are subject to market risks, please carry out your due diligence before investing. And last but not the least, past performance is not indicative of future returns.
1. Breakout after 2018
2. Risk Reward is almost 2.5.
3. Did not fall even Nifty fall
Disclaimer:
Content shared on or through social site channels are for information and education purposes only and should not be treated as investment or trading advice. Please do your own analysis or take independent professional financial advice before making any investments based on your own personal circumstances. Investment in securities are subject to market risks, please carry out your due diligence before investing. And last but not the least, past performance is not indicative of future returns.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.